Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function - Breitkreutz, Iris; Kosely, Florentina; Heining, Christoph; Hillengaß, Jens; Egerer, Gerlinde; Ho, Anthony Dick; Goldschmidt, Hartmut; Raab, Marc-Steffen (Hematological oncology, 2016)
First published: 18 March 2015